ATC code A02
ATC code A02 Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A02 is part of the anatomical group A Alimentary tract and metabolism.[4]
| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Drugs for constipation |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A02A Antacids
A02AA Magnesium compounds
- A02AA01 Magnesium carbonate
- A02AA02 Magnesium oxide
- A02AA03 Magnesium peroxide
- A02AA04 Magnesium hydroxide
- A02AA05 Magnesium silicate
- A02AA10 Combinations
A02AB Aluminium compounds
- A02AB01 Aluminium hydroxide
- A02AB02 Algeldrate
- A02AB03 Aluminium phosphate
- A02AB04 Dihydroxialumini sodium carbonate
- A02AB05 Aluminium acetoacetate
- A02AB06 Aloglutamol
- A02AB07 Aluminium glycinate
- A02AB10 Combinations
A02AC Calcium compounds
- A02AC01 Calcium carbonate
- A02AC02 Calcium silicate
- A02AC10 Combinations
A02AD Combinations and complexes of aluminium, calcium and magnesium compounds
- A02AD01 Ordinary salt combinations
- A02AD02 Magaldrate
- A02AD03 Almagate
- A02AD04 Hydrotalcite
- A02AD05 Almasilate
A02AF Antacids with antiflatulents
- A02AF01 Magaldrate and antiflatulents
- A02AF02 Ordinary salt combinations and antiflatulents
A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BA H2-receptor antagonists
- A02BA01 Cimetidine
- A02BA02 Ranitidine
- A02BA03 Famotidine
- A02BA04 Nizatidine
- A02BA05 Niperotidine
- A02BA06 Roxatidine
- A02BA07 Ranitidine bismuth citrate
- A02BA08 Lafutidine
- A02BA51 Cimetidine, combinations
- A02BA53 Famotidine, combinations
A02BB Prostaglandins
- A02BB01 Misoprostol
- A02BB02 Enprostil
A02BC Proton pump inhibitors
- A02BC01 Omeprazole
- A02BC02 Pantoprazole
- A02BC03 Lansoprazole
- A02BC04 Rabeprazole
- A02BC05 Esomeprazole
- A02BC06 Dexlansoprazole
- A02BC07 Dexrabeprazole
- A02BC08 Vonoprazan
- A02BC09 Tegoprazan
- A02BC53 Lansoprazole, combinations
- A02BC54 Rabeprazole, combinations
A02BD Combinations for eradication of Helicobacter pylori
- A02BD01 Omeprazole, amoxicillin and metronidazole
- A02BD02 Lansoprazole, tetracycline and metronidazole
- A02BD03 Lansoprazole, amoxicillin and metronidazole
- A02BD04 Pantoprazole, amoxicillin and clarithromycin
- A02BD05 Omeprazole, amoxicillin and clarithromycin
- A02BD06 Esomeprazole, amoxicillin and clarithromycin
- A02BD07 Lansoprazole, amoxicillin and clarithromycin
- A02BD08 Bismuth subcitrate, tetracycline and metronidazole
- A02BD09 Lansoprazole, clarithromycin and tinidazole
- A02BD10 Lansoprazole, amoxicillin and levofloxacin
- A02BD11 Pantoprazole, amoxicillin, clarithromycin and metronidazole
- A02BD12 Rabeprazole, amoxicillin and clarithromycin
- A02BD13 Rabeprazole, amoxicillin and metronidazole
- A02BD14 Vonoprazan, amoxicillin and clarithromycin
- A02BD15 Vonoprazan, amoxicillin and metronidazole
- A02BD16 Omeprazole, amoxicillin and rifabutin
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
- A02BX01 Carbenoxolone
- A02BX02 Sucralfate
- A02BX03 Pirenzepine
- A02BX04 Methiosulfonium chloride
- A02BX05 Bismuth subcitrate
- A02BX06 Proglumide
- A02BX07 Gefarnate
- A02BX08 Sulglicotide
- A02BX09 Acetoxolone
- A02BX10 Zolimidine
- A02BX11 Troxipide
- A02BX12 Bismuth subnitrate
- A02BX13 Alginic acid
- A02BX14 Rebamipide
- A02BX51 Carbenoxolone, combinations excluding psycholeptics
- A02BX71 Carbenoxolone, combinations with psycholeptics
- A02BX77 Gefarnate, combinations with psycholeptics
A02X Other drugs for acid related disorders
- Empty
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code A02". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QA02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.